Enteric Empty Capsules Market Share, Size, Trends, Industry Analysis Report: By Product (Gelatin Capsules and Vegetable Capsules), By Application, By End User, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2024–2032
- Published Date:Sep-2024
- Pages: 119
- Format: PDF
- Report ID: PM5041
- Base Year: 2023
- Historical Data: 2019-2022
Enteric Empty Capsules Market Overview
The global enteric empty capsules market size was valued at USD 2.88 billion in 2023. The market is projected to grow from USD 3.08 billion in 2024 to USD 5.21 billion by 2032, exhibiting a CAGR of 6.8% during forecast period.
The enteric empty capsules market involves the production and use of capsules coated to resist stomach acid and dissolve in the intestines, enhancing drug delivery and supplement absorption by protecting sensitive ingredients until reaching the intestinal tract.
The global enteric empty capsules market is witnessing significant growth, driven by the increasing demand for targeted drug delivery systems that enhance the bioavailability and efficacy of active pharmaceutical ingredients. Enteric capsules, designed to withstand the acidic environment of the stomach and release their contents in the intestines, are increasingly preferred in the formulation of drugs for conditions such as inflammatory bowel disease (IBD) and acid-sensitive medications. An emerging trend in the market is the shift toward plant-based capsules, driven by the rising demand for vegetarian and vegan alternatives. Additionally, advancements in capsule manufacturing technologies, such as the use of innovative polymers that improve enteric coating properties, propel the market growth. The expanding nutraceuticals industry, with its emphasis on gut health supplements, also contributes to the rising demand for enteric capsules globally.
To Understand More About this Research: Request a Free Sample Report
Enteric Empty Capsules Market Trends
Rising Shift Toward Plant-Based Capsules
As consumers become more health-conscious and aware of dietary restrictions, there is a growing demand for vegetarian and vegan alternatives in pharmaceuticals and nutraceuticals. Plant-based enteric capsules, typically made from materials such as hydroxypropyl methylcellulose (HPMC), offer a viable solution to meet this demand. They provide the same protective properties like gelatin capsules but align with the preferences of a broader demographic, including those with dietary, ethical, or religious restrictions. This trend is driving innovation in capsule manufacturing, with companies focusing on developing high-quality, plant-based enteric capsules that do not compromise on performance.
Advancements in Enteric Coating Technologies
Advancements in enteric coating technologies are crucial for ensuring that capsules release their contents in the intestines rather than in the stomach. Innovations in polymer science have led to the development of new enteric coatings that offer improved stability, controlled release, and enhanced protection of sensitive active ingredients. These advancements are particularly important for medications targeting gastrointestinal conditions or for acid-sensitive drugs, where precise delivery is critical. Companies are investing in research and development to create more efficient and reliable enteric coatings. Thus, the advancements in enteric coating technologies are expected to boost the adoption of enteric capsules in various therapeutic areas in the coming years.
Rising Demand from Nutraceuticals Industry
As consumer interest in health and wellness products continues to rise, there is an increasing demand for supplements that target gut health, including probiotics and other gastrointestinal health products. Enteric capsules are particularly well-suited for these applications as they protect active ingredients from the harsh acidic environment of the stomach, ensuring that they reach the intestines where they can be most effective. Since nutraceutical companies seek reliable delivery systems that enhance the efficacy of their products, the demand for enteric empty capsules is rising. Therefore, the growing nutraceuticals industry is expected to be a key trend positively impacting the global enteric empty capsules market during the forecast period.
Enteric Empty Capsules Market Segment Insights
Enteric Empty Capsules Market – Product Insights
The gelatin capsules segment dominates the global enteric empty capsules market, primarily due to their wide availability, cost-effectiveness, and established use in pharmaceutical and nutraceutical applications. Gelatin capsules, derived from animal sources, have been favored for their excellent film-forming properties, which contribute to their effectiveness in protecting active ingredients until they reach the intestines. The segment's strong market presence is further supported by its extensive use in a variety of medications, including those for conditions requiring enteric protection, such as inflammatory bowel diseases.
The vegetable capsules segment is experiencing a higher growth rate in the enteric empty capsules market. This surge is driven by the increasing consumer preference for plant-based and non-animal-derived products, fueled by growing health consciousness, dietary restrictions, and ethical concerns. Vegetable capsules, typically made from materials such as hydroxypropyl methylcellulose (HPMC), are gaining popularity, particularly in the nutraceuticals sector, where there is a significant demand for vegetarian and vegan-friendly supplements. Additionally, advancements in the formulation of vegetable capsules have improved their enteric properties, making them a viable alternative to gelatin capsules. This shift toward plant-based options is expected to continue, potentially altering the market dynamics in the coming years.
Enteric Empty Capsules Market – Application Insights
The antibiotic & antibacterial drugs segment dominates the global enteric empty capsules market, owing to the widespread use of enteric capsules in delivering medications that require protection from the acidic environment of the stomach. These drugs often contain active ingredients that can be degraded by stomach acid, necessitating enteric coating to ensure they reach the intestines intact, where absorption occurs. The high incidence of bacterial infections and the ongoing need for effective treatments have solidified this segment’s leading position in the market.
The antacid & antiflatulent preparations segment is experiencing the highest growth rate. The rising prevalence of gastrointestinal disorders, including acid reflux, indigestion, and related conditions, has led to an increased demand for targeted treatments that provide relief without causing irritation in the stomach. Enteric capsules are particularly beneficial for these preparations, as they can deliver active ingredients directly to the intestines, enhancing efficacy and reducing potential side effects. As awareness of digestive health continues to grow, particularly in aging populations and regions with high incidences of gastrointestinal issues, this segment is expected to expand rapidly, contributing significantly to overall market growth.
Enteric Empty Capsules Market – End User Insights
The pharmaceutical manufacturers segment dominates the global enteric empty capsules market, largely due to the extensive use of enteric capsules in the formulation of prescription drugs, particularly those requiring targeted delivery to the intestines. Pharmaceutical companies rely on enteric capsules for a wide range of medications, including antibiotics and anti-inflammatory drugs and treatments for gastrointestinal disorders. The segment's dominance is supported by the high demand for precise drug delivery systems that ensure the efficacy and stability of active ingredients, which is critical in pharmaceutical applications.
The nutraceutical manufacturers segment is experiencing the highest growth rate, driven by the increasing consumer focus on health and wellness, leading to a rising demand for dietary supplements, probiotics, and other gut health products that benefit from enteric delivery. As the nutraceutical industry expands, fueled by the rising inclination toward clean-label products and plant-based alternatives, manufacturers are increasingly adopting enteric capsules to enhance the effectiveness of their offerings. The broader trend of consumers seeking preventive health measures propels the demand for nutraceuticals, which is expected to drive the requirement for enteric capsules in the nutraceutical industry in the coming years.
Enteric Empty Capsules Market, Segmental Coverage, 2019 - 2032 (USD billion)
Source: Secondary Research, Primary Research, PMR Database and Analyst Review
Enteric Empty Capsules Market – Regional Insights
By region, the study provides the market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominates the global enteric empty capsules market, primarily due to its advanced pharmaceutical industry, high healthcare expenditure, and strong presence of leading pharmaceutical and nutraceutical manufacturers. The region's dominance is further supported by the growing prevalence of chronic diseases, which drives demand for targeted drug delivery systems such as enteric capsules. Additionally, North America's well-established regulatory framework and emphasis on research and development contribute to the rapid adoption of innovative enteric capsule technologies. Europe and Asia Pacific are significant markets, with Europe benefiting from a robust pharmaceutical sector and Asia Pacific experiencing rapid growth due to increasing healthcare investments. However, North America holds the largest market share due to the technological advancements and market maturity.
Enteric Empty Capsules Market Regional Coverage, 2019 - 2032 (USD billion)
Source: Secondary Research, Primary Research, PMR Database and Analyst Review
In Europe, the global enteric empty capsules market is characterized by a strong and mature pharmaceutical industry, particularly in countries such as Germany, the UK, and France. The regional market benefits from a robust regulatory framework that ensures high standards in drug formulation and manufacturing, driving demand for enteric capsules. Europe also has a significant nutraceutical market, with growing consumer awareness about health and wellness, contributing to increased adoption of enteric capsules in dietary supplements. The focus on innovation, combined with government support for research and development in the pharmaceutical sector, positions Europe as a key player in the global market, with steady growth prospects.
The enteric empty capsules market in Asia Pacific is experiencing rapid growth, fueled by expanding healthcare infrastructure, rising healthcare spending, and increasing awareness of advanced drug delivery systems. Countries such as China, India, and Japan are at the forefront of this growth, owing to their large populations and the growing prevalence of chronic diseases. The region's pharmaceutical and nutraceutical industries are also booming, with significant investments in R&D and manufacturing capabilities. Additionally, the rising demand for generic drugs and dietary supplements in Asia Pacific is propelling the adoption of enteric capsules in the region.
Enteric Empty Capsules Market – Key Market Players & Competitive Insights
Capsugel (a Lonza company); ACG Group; Qualicaps; Suheung Co., Ltd.; Sunil Healthcare Ltd.; Roxlor, LLC; Medi-Caps Ltd.; Natural Capsules Ltd.; Capscanada Corporation; Snail Pharma Industry Co., Ltd.; Bright Pharma Caps, Inc.; Patheon (a Thermo Fisher Scientific brand); Erawat Pharma Limited; Dah Feng Capsule Co., Ltd.; and Shaoxing Kangke Capsule Co., Ltd. are a few of the key players in the global enteric empty capsules market. These companies are recognized for their extensive product portfolios, strong market presence, and continuous innovation in the development of enteric capsules for pharmaceutical and nutraceutical applications.
In terms of competitive analysis, Capsugel (Lonza) and ACG Group are among the major players, holding significant market shares due to their advanced manufacturing capabilities, global distribution networks, and strong focus on research and development. These companies have invested heavily in innovative technologies, such as plant-based enteric capsules and advanced enteric coatings, to cater to the evolving demands of the market. Qualicaps and Suheung Co., Ltd. also maintain a strong position with their diversified product offerings and emphasis on high-quality standards, making them preferred suppliers for pharmaceutical and nutraceutical manufacturers worldwide.
The competitive landscape of the market is shaped by ongoing innovation and strategic partnerships. Key players are increasingly focusing on expanding their product lines with specialized capsules, such as those designed for targeted drug delivery and enhanced bioavailability. Additionally, mergers and acquisitions are common strategies employed by market leaders to strengthen their market position and broaden their global footprint. As the demand for enteric capsules continues to rise, especially in the nutraceutical sector, companies are likely to invest in R&D and explore new materials and technologies to maintain a competitive edge in this dynamic market.
Capsugel (a Lonza company) is one of the major players in the global enteric empty capsules market. Known for its extensive range of capsule solutions, including gelatin and plant-based options, Capsugel has a strong presence in the pharmaceutical and nutraceutical industries. The company is recognized for its innovative capsule technologies, such as its DRcaps designed for delayed-release applications, which cater to the growing demand for targeted drug delivery systems. Capsugel's commitment to research and development, coupled with its global manufacturing capabilities, has solidified its leadership in the market.
ACG Group is another major player in the market, offering a comprehensive range of capsule solutions that cater to various therapeutic areas. The company is particularly known for its focus on high-quality manufacturing processes and sustainable practices, with a growing portfolio of plant-based capsules that align with current consumer trends. The company has a strong global presence, with manufacturing facilities and distribution networks spanning multiple continents.
Key Companies in Enteric Empty Capsules Market
- Capsugel (a Lonza company)
- ACG Group
- Qualicaps
- Suheung Co., Ltd.
- Sunil Healthcare Ltd.
- Roxlor, LLC
- Medi-Caps Ltd.
- Natural Capsules Ltd.
- Capscanada Corporation
- Snail Pharma Industry Co., Ltd.
- Bright Pharma Caps, Inc.
- Patheon (a Thermo Fisher Scientific brand)
- Erawat Pharma Limited
- Dah Feng Capsule Co., Ltd.
- Shaoxing Kangke Capsule Co., Ltd.
Enteric Empty Capsules Industry Developments
- In June 2024, Lonza announced an expansion of its capsule manufacturing capacity to meet the increasing demand for specialty capsules, further strengthening its market position.
- In May 2024, ACG launched a new line of enteric capsules specifically designed for nutraceutical products, responding to the rising demand for gut health supplements and other targeted applications. This move highlights ACG's proactive approach to market trends and its commitment to innovation in capsule technology.
Enteric Empty Capsules Market Segmentation
Enteric Empty Capsules Market – Product Outlook
- Gelatin Capsules
- Vegetable Capsules
Enteric Empty Capsules Market – Application Outlook
- Antacid & Antiflatulent Preparations
- Antibiotic & Antibacterial Drugs
- Others
Enteric Empty Capsules Market – End User Outlook
- Pharmaceutical Manufacturers
- Nutraceutical Manufacturers
- Others
Enteric Empty Capsules – Regional Outlook
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Enteric Empty Capsules Report Scope
|
Report Attributes |
Details |
|
Market size value in 2023 |
USD 2.88 billion |
|
Market size value in 2024 |
USD 3.08 billion |
|
Revenue forecast in 2032 |
USD 5.21 billion |
|
CAGR |
12.90% from 2024 to 2032 |
|
Base year |
2023 |
|
Historical data |
2019–2022 |
|
Forecast period |
2024–2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
|
Report coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments covered |
|
|
Regional scope |
|
|
Competitive landscape |
|
|
Report format |
|
|
Customization |
Report customization as per your requirements with respect to countries, region, and segmentation. |
How the report is valuable for an organization?
Workflow/Innovation Strategy: The enteric empty capsules market has been segmented on the basis of product, application, and end user. Moreover, the study provides the reader with a detailed understanding of the different segments at global and regional level.
Growth/Marketing Strategy: To capitalize on the growing demand for enteric empty capsules, companies in the global market are focusing on several key growth and marketing strategies. Emphasizing innovation, they are investing in the development of advanced capsule technologies, such as plant-based and specialty coatings, to meet diverse consumer and therapeutic needs. Strategic partnerships and acquisitions are being pursued to enhance market reach and production capabilities. Additionally, companies are expanding their presence in emerging markets through localized manufacturing and distribution networks.
FAQ's
The global enteric empty capsules market size was valued at USD 2.88 billion in 2023 and is projected to grow to USD 5.21 billion by 2032.
The global market is projected to register a CAGR of 6.8% during 2023–2032.
North America accounted for the largest market share in 2023.
Capsugel (a Lonza company); ACG Group; Qualicaps, Suheung Co., Ltd.; Sunil Healthcare Ltd.; Roxlor, LLC; Medi-Caps Ltd.; Natural Capsules Ltd.; Capscanada Corporation; Snail Pharma Industry Co., Ltd.; Bright Pharma Caps, Inc.; Patheon (a Thermo Fisher Scientific brand); Erawat Pharma Limited; Dah Feng Capsule Co., Ltd.; and Shaoxing Kangke Capsule Co., Ltd. are among the major market players.
The gelatin capsules segment dominated the market in 2023.
The antibiotic & antibacterial drugs segment held the largest share of the global market in 2023.
Enteric empty capsules are specially designed capsules used in the pharmaceutical and nutraceutical industries to deliver active ingredients in a way that protects them from the acidic environment of the stomach and ensures their release in the intestines.
A few key trends in the enteric empty capsules market are described below. Shift Toward Plant-Based Capsules: Increasing preference for vegetarian and vegan alternatives boosts the development and adoption of plant-based enteric capsules, made from materials such as hydroxypropyl methylcellulose (HPMC). Advancements in Coating Technologies: Innovations in enteric coating materials and techniques are enhancing the effectiveness and reliability of capsules, ensuring more precise drug delivery and improved protection for sensitive ingredients. Rising Demand from Nutraceuticals: The growing focus on health and wellness propelled the use of enteric capsules in dietary supplements, especially those targeting gut health and probiotics.
For a new company entering the enteric empty capsules market, focusing on innovation and differentiation can provide a competitive edge. Prioritizing the development of advanced capsule technologies, such as plant-based or personalized enteric coatings, will cater to the growing demand for sustainable and targeted delivery solutions. Building strong partnerships with pharmaceutical and nutraceutical companies can enhance market entry and expansion opportunities. Additionally, investing in research and development to address emerging health trends, such as gut health and precision medicine, will boost the position of the company in the global market. Leveraging digital marketing and customer engagement strategies can also help in building brand recognition and capturing market share effectively.
Companies manufacturing and distributing enteric empty capsules and related products and other consulting firms must buy the report.
